Evidence map›Paper›PMID 11772394›Full record

ArticleThe Biochemical journal2002

abf-1 and abf-2, ASABF-type antimicrobial peptide genes in Caenorhabditis elegans.

Yusuke Kato, Tomoyasu Aizawa, Hirokazu Hoshino, Keiichi Kawano, Katsutoshi Nitta, Hong Zhang

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. BMP signaling to pharyngeal muscle in theMolecular biology of the cell · 2024
    Article
  5. BMP signaling to pharyngeal muscle in thebioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Frontiers in immunology · 2023
    Article
  8. Article
  9. A Potential ProbioticAntioxidants (Basel, Switzerland) · 2022
    Article
  10. Take a Walk to the Wild Side ofMicrobiology and molecular biology reviews : MMBR · 2021
    Review
  11. Innate immunity in C. elegans.Current topics in developmental biology · 2021
    Review
  12. Caenorhabditis elegans: a model to understand host-microbe interactions.Cellular and molecular life sciences : CMLS · 2020
    Review
  13. Review
  14. Worms' Antimicrobial Peptides.Marine drugs · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. The Intestinal RoundwormFrontiers in cellular and infection microbiology · 2018
    Article
  19. Article
  20. Reciprocal Interactions between Nematodes and Their Microbial Environments.Frontiers in cellular and infection microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yusuke KatoDepartment of Developmental Biology, National Institute of Agrobiological Sciences, Oowashi 1-2, Tsukuba, Ibaraki 305-8634, Japan. kato@affrc.go.jp
Tomoyasu Aizawa
Hirokazu Hoshino
Keiichi Kawano
Katsutoshi Nitta
Hong Zhang
Hokkaido University · JPInstitute of Agrobiological Sciences · JPBio-oriented Technology Research Advancement Institution · JPTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two genes encoding the ASABF (Ascaris suum antibacterial factor)-type antimicrobial peptide, abf-1 and abf-2, were identified in Caenorhabditis elegans. Recombinant ABF-2 exhibited potent microbicidal activity against Gram-positive and Gram-negative bacteria, and yeasts. The tissue-specific distribution estimated by immunofluorescence staining and transgenic analysis of a gfp fusion gene (where GFP corresponds to green fluorescent protein) suggested that ABF-2 contributes to surface defence in the pharynx. abf-1 contains a single intron at a conserved position, suggesting that asabf and abf originated from a common ancestor. Both transcripts for abf-1 and abf-2 were detected as two distinct forms, i.e. spliced leader (SL)1-trans-spliced with a long 5'-untranslated region (UTR) and SL-less with a short 5'-UTR. A polycistronic precursor RNA encoding ABF-1 and ABF-2 was detected, suggesting that these genes form an operon. An 'opportunistic operon' model for regulation of abf genes, including the generation of short SL-less transcripts, is proposed. In conclusion, C. elegans should have an immune defence system due to the antimicrobial peptides. C. elegans can be a novel model for innate immunity. Furthermore, the combination of biochemical identification in Ascaris suum and homologue hunting in C. elegans should be a powerful method of finding rapidly evolved proteins, such as some immune-related molecules in C. elegans.

Indexed as

Caenorhabditis elegans ProteinsDNA-Binding ProteinsPeptidesAmino Acid SequenceAnimalsAnti-Bacterial AgentsBase SequenceBasic Helix-Loop-Helix ProteinsCaenorhabditis elegansCloning, MolecularDNA, ComplementaryDNA PrimersFluorescent Antibody TechniqueHelminth ProteinsOperonPolymerase Chain Reactionabf-1 protein, C elegansAnti-Bacterial AgentsASABF protein, Ascaris suumBasic Helix-Loop-Helix ProteinsCaenorhabditis elegans ProteinsDNA-Binding ProteinsDNA, ComplementaryDNA PrimersHelminth ProteinsPeptidesRecombinant ProteinsRNA, MessengerTranscription Factors

Identifiers

PMID11772394
PMCPMC1222302
OpenAlexW2073401690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.